Article
Demographic Representation of a Decentralized Long COVID Trial: A Comparison with the 2023 National Health Interview Survey
2024-11-27
Abstract excerpt
<h4>ABSTRACT</h4> <h4>Importance</h4> Clinical trials can be a chokepoint to progress in medicine. They are commonly expensive, slow, and not participant-centric. Ensuring patient-centric, equitable trials with diverse demographic representation is essential for developing generalizable treatments and reducing healthcare disparities. Thus, there is an urgent need to test new ways of conducting clinical trials. The...
Topics
Open a Topic to create a Post that cites this publication.
Identifiers and source
- Literature Corpus work
- 6d7315ab-6eea-5fb1-995a-26680aaade17
- DOI
- 10.1101/2024.11.25.24317941
